baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out MRK/ DE000GG2DE08 /

2024-09-20 9:36:24 PM	Chg.+0.02	Bid10:00:26 PM	Ask10:00:26 PM	Underlying	Strike price	Expiration date	Option type
5.33EUR	+0.38%	- Bid Size: -	- Ask Size: -	Merck and Co Inc	176.4671 USD	2078-12-31	Put

GlobeNewswire 07-31 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease

TeleTrader 07-30 Merck's Q2 sales up 7% to $16.1 billion

GlobeNewswire 07-17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...

TeleTrader 07-01 US closes higher after data

GlobeNewswire 06-27 Verizon elects Caroline A. Litchfield to its Board of Directors

GlobeNewswire 06-26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors

GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...

GlobeNewswire 06-06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...

GlobeNewswire 05-30 Monte Rosa Therapeutics Announces Leadership Team Promotions

TeleTrader 05-28 US markets turn to losses, Dow plunges 330 points

GlobeNewswire 05-28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

GlobeNewswire 05-23 IO Biotech to Present at Jefferies Global Healthcare Conference

GlobeNewswire 05-23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

GlobeNewswire 05-16 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-14 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights

GlobeNewswire 05-08 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire 04-25 American Kidney Fund Launches National Kidney Health Equity Media Campaign

TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 04-24 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...

GlobeNewswire 04-18 The New York Academy of Medicine Announces New Board of Trustee Members

GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness

GlobeNewswire 04-09 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...

GlobeNewswire 04-05 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer

GlobeNewswire 04-03 TOMI Environmental Solutions Receives Gold Safety Award from Highwire

GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

Goldman Sachs Knock-Out MRK/ DE000GG2DE08 /

If you wish to receive reply to your feedback, please provide your email address.